Manhard Kimberly
- SEC CIK
- 0001202094
In the past year, 2 open-market sale filings worth $279.0K and no purchases.
Current role at each company
- INBX Inhibrx Biosciences, Inc.Directoras of Sep 18, 2026
- Inhibrx, Inc.Directoras of May 30, 2024
- HRTX Heron Therapeutics, Inc.EVP, Drug Developmentas of Apr 17, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $279.0K
- 2 filings
- Net
- −$279.0K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Manhard Kimberly as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
INBX Inhibrx Biosciences, Inc.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 30, 2024 (view filing) | Aug 28 | 2 days | Manhard KimberlyDirector | PPurchase | +10.0K | $13.98 | +$139.8K | New position10.0K after | |
| Sep 10, 2026 (view filing)7:06 PM ET | Sep 8-9 | 2 days | Manhard KimberlyDirector | SSale | −1.00K | $115.47 | −$115.5K | −10.0%9.00K after | 2 lots |
| Sep 15, 2026 (view filing)5:52 PM ET | Sep 11-15 | 4 days | Manhard KimberlyDirector | SSale | −1.50K | $109.03 | −$163.5K | −16.7%7.50K after | 3 lots |
HRTX Heron Therapeutics, Inc.
EVP, Drug Development1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 4, 2022 (view filing) | May 3 | 1 day | Manhard KimberlyEVP, Drug Development | SSale | −1.50K | $4.76 | −$7.16K | −12.2%10.9K after |